Pieter Van Vlierberghe
Gent, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 129 publications
Profiling histone post-translational modifications to identify signatures of epigenetic drug response in T-cell acute lymphoblastic leukemia.
Journal: Scientific reports
Published: October 14, 2025
Editor's Note: A Novel L-Asparaginase with low L-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias In Vivo.
Journal: Cancer research
Published: August 06, 2025
Benchmarking the paediatric T-cell ALL subtype classifier, TALLSorts.
Journal: British journal of haematology
Published: June 02, 2025
CCR1 inhibition sensitizes multiple myeloma cells to glucocorticoid therapy.
Journal: Pharmacological research
Published: December 19, 2024
A dual role for PSIP1/LEDGF in T cell acute lymphoblastic leukemia.
Journal: Science advances
Published: November 01, 2024
A human-like glutaminase-free asparaginase is highly efficacious in ASNSlow leukemia and solid cancer mouse xenograft models.
Journal: Cancer letters
Published: October 28, 2024
BCAT1 is a NOTCH1 target and sustains the oncogenic function of NOTCH1.
Journal: Haematologica
Published: March 29, 2024
Tet2 is a tumor suppressor in the preleukemic phase of T-cell acute lymphoblastic leukemia.
Journal: Blood advances
Published: October 24, 2023
Targeting hyperactive platelet-derived growth factor receptor-β signaling in T-cell acute lymphoblastic leukemia and lymphoma.
Journal: Haematologica
Published: August 17, 2023
Myb overexpression synergizes with the loss of Pten and is a dependency factor and therapeutic target in T-cell lymphoblastic leukemia.
Journal: HemaSphere
Published: August 14, 2023
Last Updated: 09/26/2026